Objectives: We have developed and utilized a computerized clinical pathway (CP) system for community-acquired pneumonia (CAP). The quality of pneumonia treatment and the effectiveness of the CP system were evaluated by clinical indicators (Cls).
Methods: We introduced a CP system from September through December 2005, and implemented it for the inpatients therapy for CAP with non-ICU settings. The CP system consisted of four pathways: CAP, atypical pneumonia, mild or moderate aspiration pneumonia, and severe aspiration pneumonia. We utilized Cls as the parameters for effectiveness of the CP system. Cls included success rate of initial antimicrobial therapy, average length of hospital stay, and pneumonia mortality rate as the outcome indicators; CP implementation rate and detection rate of pneumonia pathogen as the process indicators. The quality of CP treatment was periodically analyzed with these Cls for the CAP in patients every six months from April 2005.
Results: The improvement of success rate of initial antimicrobial therapy (80.0→83.3→83.7→82.2→87.5%) was observed in concordance with increase of the CP implementation rate (4.6→61.4→91.3→94.1→96.1%) from April 2005 to September 2007, and the average length of hospital stay decreased remarkably. The detection rate of pneumonia pathogen was 44%, and Streptococcus pneumoniae was the most common (44%). New CPs were added based on the process indicator regarding the detection rate of pneumonia pathogen. A further improvement of the success rate of initial antimicrobial therapy and the CP implementation rate was observed after introducing the new CPs. The pneumonia mortality rate showed gradual decrease of about 5%.
Conclusion: The Cls for pneumonia therapy could be utilized as parameters for evaluating the effectiveness of the pneumonia treatment with CPs and the improvement of the CP system.
View full abstract